Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Stadler

Showing results (221-230 of 724) with videos related to

Pageof 73
Sort By:
Phytochemistry|April 28, 2001
Concentricol, a taxonomically significant triterpenoid from Daldinia concentricaM Stadler, M Baumgartner, T Grothe, et al.
European Journal of Immunology|September 1, 1988
Stimulation-dependent lymphokine mRNA levels in human mononuclear cellsJ F Gauchat, C Walker, A L De Weck, et al.
European Journal of Immunology|November 1, 1989
Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cellsS Brantschen, J F Gauchat, A L De Weck, et al.
Lymphokine Research|January 1, 1986
Relation of supernatant IL-2 to steady state levels of IL-2 mRNAJ F Gauchat, C Walker, A L De Weck, et al.
Clinical Trials (London, England)|December 27, 2023
Optimizing the doses of cancer drugs after usual dose findingGarth W Strohbehn, Walter M Stadler, Philip S Boonstra, et al.
Immunology Letters|August 3, 2010
DARPins against a functional IgE epitopeMichael J Baumann, Alexander Eggel, Patrick Amstutz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodiesB M Stadler, E H Berenstein, R P Siraganian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancerW M Stadler, T Kuzel, B Roth, et al.
Anti-Cancer Drugs|June 19, 2004
Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cellsJonathan C Berger, Donald Vander Griend, Walter M Stadler, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancerM Chien, M Astumian, D Liebowitz, et al.
Pageof 73

Showing results (221-230 of 724) with videos related to

Sort By:
Pageof 73
Phytochemistry|April 28, 2001
Concentricol, a taxonomically significant triterpenoid from Daldinia concentricaM Stadler, M Baumgartner, T Grothe, et al.
European Journal of Immunology|September 1, 1988
Stimulation-dependent lymphokine mRNA levels in human mononuclear cellsJ F Gauchat, C Walker, A L De Weck, et al.
European Journal of Immunology|November 1, 1989
Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cellsS Brantschen, J F Gauchat, A L De Weck, et al.
Lymphokine Research|January 1, 1986
Relation of supernatant IL-2 to steady state levels of IL-2 mRNAJ F Gauchat, C Walker, A L De Weck, et al.
Clinical Trials (London, England)|December 27, 2023
Optimizing the doses of cancer drugs after usual dose findingGarth W Strohbehn, Walter M Stadler, Philip S Boonstra, et al.
Immunology Letters|August 3, 2010
DARPins against a functional IgE epitopeMichael J Baumann, Alexander Eggel, Patrick Amstutz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1982
Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodiesB M Stadler, E H Berenstein, R P Siraganian, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancerW M Stadler, T Kuzel, B Roth, et al.
Anti-Cancer Drugs|June 19, 2004
Metastasis suppressor genes: signal transduction, cross-talk and the potential for modulating the behavior of metastatic cellsJonathan C Berger, Donald Vander Griend, Walter M Stadler, et al.
Cancer Chemotherapy and Pharmacology|June 15, 1999
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancerM Chien, M Astumian, D Liebowitz, et al.
Pageof 73